Literature DB >> 19077606

Decreasing magnitude of multiple organ dysfunction syndrome despite increasingly severe critical surgical illness: a 17-year longitudinal study.

Philip S Barie1, Lynn J Hydo, Jian Shou, Soumitra R Eachempati.   

Abstract

BACKGROUND: Multiple organ dysfunction syndrome (MODS) remains prevalent and the leading cause of mortality in the surgical intensive care unit (ICU). Improvements in ICU care in the last 10 years (e.g., tight glycemic control, activated protein C, fewer transfusions causing fewer nosocomial infections) may have decreased the incidence, magnitude, and mortality of MODS, as hypothesized in this study.
METHODS: Longitudinal 17-year prospective study of 11,314 ICU patients (academic/tertiary unit, Level I trauma center), 5,157 (45.5%) of whom developed any degree of MODS (Marshall score, cumulative). Data collected included Admission Acute Physiology and Chronic Health Evaluation (APACHE)-II and APACHE-III scores, MOD score (MODsc), hospital mortality, and the incidence and magnitude of MODS. The ratio of MODsc: APACHE III was calculated. Analyses (X +/- SEM, chi2, repeated-measures ANOVA, linear and polynomial regression, c-statistic) were performed for calendar-year intervals beginning in 1990 through 2006.
RESULTS: Among MODS patients, the mean MODsc was 6.3 +/- 0.1 points, and the mortality rate was 22%. The APACHE III score increased significantly (p < 0.0001) over time, but the mortality rate was unchanged (r2 = 0.02). Adjusted for illness severity (MODsc:A3), the magnitude of MODS decreased significantly (p < 0.0001) during the time period.
CONCLUSIONS: Despite significant increases in admission APACHE III score over 17 years, the adjusted magnitude of MODS (MODsc:A3) decreased. Given the strong association between MODS and mortality for critically ill surgical patients, it is likely that the unchanged risk-adjusted mortality observed over time is due to the reduced magnitude of MODS.

Entities:  

Mesh:

Year:  2008        PMID: 19077606     DOI: 10.1097/TA.0b013e31818c12dd

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  4 in total

1.  Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice.

Authors:  H W Wang; W Yang; J Y Lu; G Tian; F Li; X H Wang; J R Kang; Y Yang
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

2.  N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model.

Authors:  Hong-Wei Wang; Wen Yang; Jiang-Yang Lu; Fei Li; Jun-Zhong Sun; Wen Zhang; Nan-Nan Guo; Lei Gao; Jia-Rui Kang
Journal:  J Clin Immunol       Date:  2012-12-16       Impact factor: 8.317

3.  Continuous blood purification ameliorates clinical signs and corrects the plasma phospholipid levels of patients with multiple organ dysfunction syndromes.

Authors:  Wei Wen; Kun Wang; Zhi-Ming Jiang; Zhong-Hui Zhang; Lei Zhou
Journal:  J Clin Lab Anal       Date:  2018-02-18       Impact factor: 2.352

Review 4.  Scoring System for Multiple Organ Dysfunction in Adult Horses with Acute Surgical Gastrointestinal Disease.

Authors:  E McConachie; S Giguère; M H Barton
Journal:  J Vet Intern Med       Date:  2016-06-14       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.